Mostrar registro simples

dc.contributor.authorMeissner, Rosely de Vasconcellospt_BR
dc.contributor.authorCovas, Dimas T.pt_BR
dc.contributor.authorDias, Paula Menna Barretopt_BR
dc.contributor.authorJob, Fani Martinspt_BR
dc.contributor.authorLeite, Marciapt_BR
dc.contributor.authorNardi, Nance Beyerpt_BR
dc.date.accessioned2010-06-08T04:17:58Zpt_BR
dc.date.issued1999pt_BR
dc.identifier.issn1415-4757pt_BR
dc.identifier.urihttp://hdl.handle.net/10183/23491pt_BR
dc.description.abstractThe nature of BCR/ABL hybrid mRNA was analyzed by RT-PCR in cells from 33 patients (22 males, 11 females) with chronic myeloid leukemia (CML). b3a2 mRNA was found in 14 cases, whereas 13 patients had b2a2 mRNA and six had both kinds of mRNA, with a predominance of the b3a2 type. The type of mRNA present showed no significant correlation with age, hemoglobin level, number of leukocytes and platelets, percentage of blasts or basophils or the presence of splenomegaly at diagnosis. There was also no correlation with sex or duration of the chronic phase. When these results were combined with those reported by other groups, a significant association (P = 0.029) was observed for mRNA type vs. sex, with a predominance of men in the groups expressing b2a2 (2.68:1) and b3a2 (1.33:1). We conclude that the classification of patients according to mRNA type does not homogenize the clinical and hematological data within groups, where variance is large, nor does it allow a differentiation between groups.en
dc.format.mimetypeapplication/pdf
dc.language.isoengpt_BR
dc.relation.ispartofGenetics and molecular biology. Ribeirão Preto. Vol. 22, no. 4 (1999), p. 475-479.pt_BR
dc.rightsOpen Accessen
dc.subjectGenéticapt_BR
dc.titleAnalysis of mRNA transcripts in chronic myeloid leukemia patientspt_BR
dc.typeArtigo de periódicopt_BR
dc.identifier.nrb000293487pt_BR
dc.type.originNacionalpt_BR


Thumbnail
   

Este item está licenciado na Creative Commons License

Mostrar registro simples